Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,061.66
+20.15 (+1.93%)
Streaming Delayed Price
Updated: 2:57 PM EST, Jan 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Eli Lilly Inks Deal With Nimbus Therapeutics To Find New Obesity Drug With AI
↗
Today 13:13 EST
Under the deal, Nimbus is eligible to receive up to $1.3 billion.
Via
Stocktwits
The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026
Today 10:22 EST
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
The Great 2026 Pivot: Tech and Healthcare Surge as Broader Market Rally Hits a Wall
Today 10:05 EST
As the first week of 2026 comes to a close, the financial markets are undergoing a significant structural shift. The broad-based "rising tide" that lifted almost all sectors throughout 2025 has begun...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Novo Nordisk Offers Oral Wegovy Pill At $149 A Month Following FDA’s Approval In December: Retail Tells Shorts ‘It’s Time To Give Up’
↗
January 05, 2026
Via
Stocktwits
MarketBeat Week in Review – 12/29 - 01/02
↗
January 03, 2026
Via
MarketBeat
Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value?
↗
Today 9:30 EST
Eli Lilly offers investors safety and growth.
Via
The Motley Fool
Arrowhead Says Its Gene Silencer Doubled Zepbound's Weight Loss
↗
Today 7:30 EST
Arrowhead Pharmaceuticals said Tuesday its gene-silencing approach almost doubled the four-month weight-loss with tirzepatide.
Via
Investor's Business Daily
Motley Fool Money: Stock Market Naughty and Nice List
↗
Today 0:53 EST
There were nice companies and great CEOs in 2025, but also some duds. We discuss the stocks on each list and end by going shopping for stocks.
Via
The Motley Fool
Topics
Artificial Intelligence
Eli Lilly Heads Toward A Defining 2026 — Can It Stay Ahead Of Novo Nordisk In The GLP-1 Showdown?
↗
Today 0:49 EST
Several clinical readouts and regulatory decisions are scheduled for Eli Lilly in 2026.
Via
Stocktwits
Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List
↗
January 05, 2026
The development comes as attention remains on Hims’ longer-term business expansion initiatives.
Via
Stocktwits
2 Cash-Producing Stocks to Keep an Eye On and 1 We Ignore
January 05, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via
StockStory
Prediction: The S&P 500 $1 Trillion Club Will Double Between 2026 and 2030
↗
January 05, 2026
Several companies could see massive gains by 2030 to join the vaunted club.
Via
The Motley Fool
Topics
Stocks
The 2026 Blueprint: Five Core Stocks to Anchor Your Portfolio in a Year of AI Realization
January 05, 2026
As we cross the threshold into 2026, the financial markets have entered a sophisticated new phase. The "AI Gold Rush" of 2024 and 2025 has matured into what analysts are calling the "Era of AI...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Should Investors Be Worried That the "Magnificent Seven" Make Up 35% of the S&P 500?
↗
January 05, 2026
At the very least, investors should be concerned. There's a way to avoid the problem, though.
Via
The Motley Fool
Topics
Stocks
Top S&P500 movers in Monday's session
↗
January 05, 2026
Via
Chartmill
Flu Season's Here—This Dividend-Payer Controls the Shot Market
↗
January 05, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Death
Bank of America Issues 2026 'Priced for Perfection' Warning: Why the S&P 500 Faces a High-Stakes 'Air Pocket'
January 05, 2026
As the financial world rings in 2026, a sobering forecast from one of Wall Street’s most influential institutions has sent a ripple of caution through the markets. Bank of America (NYSE: BAC) Global...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Priced for Perfection: Bank of America Issues Stark Warning on S&P 500 Valuation for 2026
January 05, 2026
As the calendar turns to 2026, the euphoria that propelled the stock market through three consecutive years of double-digit gains is facing a sobering reality check. Bank of America (NYSE: BAC) has...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever
↗
January 05, 2026
Via
MarketBeat
Eli Lilly: Strength Meets GLP‑1 Access Momentum
↗
January 05, 2026
Eli Lilly's stock remains robust at $1,080.36 amid positive market developments, strong GLP-1 access momentum, and heightened investor interest ahead of key earnings announcements.
Via
Talk Markets
Is It Time to Dump Your Shares of Eli Lilly?
↗
January 05, 2026
Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.
Via
The Motley Fool
2 Unpopular Stocks That Deserve Some Love and 1 That Underwhelm
January 04, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...
Via
StockStory
4 Stocks to Buy in January That Could Join Nvidia in the $1 Trillion Club by 2030
↗
January 04, 2026
Visa, ExxonMobil, Oracle, and Netflix have multi-year compounding potential for patient investors.
Via
The Motley Fool
Topics
Artificial Intelligence
Prediction: These Will Be the Biggest Stock Splits for 2026
↗
January 03, 2026
Plenty of well-known companies seem ripe for stock splits -- though you shouldn't really care.
Via
The Motley Fool
The Great 2026 Rebalancing: Institutional Giants Pivot from AI Hype to Industrial Execution
January 02, 2026
As the opening bell rang for the first trading session of 2026, the financial world witnessed the commencement of what analysts are calling "The Great Rebalancing." Institutional fund managers,...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Beyond the Bot: 2026 Marks the Great Rebalancing as Investors Pivot from AI Hype to Tangible Growth
January 02, 2026
As the opening bell rings on January 2, 2026, the financial landscape looks fundamentally different from the AI-crazed atmosphere of the previous two years. The "AI Infrastructure Fever" that dominated...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
January 02, 2026
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s...
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
January 02, 2026
As the calendar turns to 2026, the landscape for weight-loss and diabetes medication has been fundamentally transformed. What began two years ago as a "wild west" of $1,000-a-month list prices and...
Via
MarketMinute
Topics
Economy
Intellectual Property
S&P 500 Tests Critical Support Levels as 2026 Kicks Off Under Technical Pressure
January 02, 2026
The S&P 500 (INDEXSP:.INX) entered the new year on a tenuous footing, grappling with a rare four-session losing streak that capped off an otherwise stellar 2025. After finishing the final trading day...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
$100 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today
↗
January 02, 2026
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.